• OPEN AN ACCOUNT
Indian Indices
Nifty
15,752.05 -28.20
(-0.18%)
Sensex
52,907.93 -111.01
( -0.21%)
Bank Nifty
33,539.45 114.35
( 0.34%)
Nifty IT
28,064.25 220.90
( 0.79%)
Global Indices
Nasdaq
11,028.74 -149.15
(-1.33%)
Dow Jones
30,775.43 -253.88
(-0.82%)
Hang Seng
21,859.79 -137.10
(-0.62%)
Nikkei 225
25,935.62 -457.42
(-1.73%)
Forex
USD-INR
78.74 0.11
(0.14%)
EUR-INR
82.59 -0.39
(-0.47%)
GBP-INR
95.74 -0.44
(-0.46%)
JPY-INR
0.58 0.00
(-0.22%)

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
540596
INE406M01024
141.0987316
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ERIS
21.71
9057.82
EPS(TTM)
Face Value()
Div & Yield %
30.68
1
0.9
 

Cipla Ltd
Cipla Ltd - Dissolution Of Inyanga Trading 386 (Pty) Limited Step-Down Wholly Owned Subsidiary
Dec 14,2021
This is to inform you that Inyanga Trading 386 (Pty) Limited (Inyanga) wholly owned subsidiary of Cipla Medpro South Africa (Pty) Limited and a wholly owned step-down subsidiary of the Company has been dissolved with effect from 10th December 2021. Inyanga was a dormant entity and this dissolution will not affect performance or revenue of the Company.